News
In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...
Flinders Health and Medical Research Institute researchers, along with colleagues in the UK and U.S., have linked brighter ...
Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization ...
Despite the global implementation of clinical algorithms designed to predict atherosclerotic cardiovascular disease based on ...
In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...
18h
The Sunday Guardian Live on MSNPREVENTING PREMATURE DEATH NEEDS SUSTAINED, COMPREHENSIVE EFFORTWhen you neglect your vital organs but focus on your fit body looks, you eventually become like a swanky car with a rundown ...
6d
HealthDay on MSNEmpagliflozin Has Kidney Protective Effects in Acute Myocardial InfarctionTotal adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.
Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results